---
type: "example"
title: "MedicinalProductDefinition Example: medicinalproductdefinition-example-equilidem-using-ingredient-and-auth"
resource: "MedicinalProductDefinition"
example: "medicinalproductdefinition-example-equilidem-using-ingredient-and-auth"
---
# MedicinalProductDefinition Example: medicinalproductdefinition-example-equilidem-using-ingredient-and-auth

## Narrative

**Generated Narrative**

**Id** : equilidem-with-ing-and-auth

**Identifier** : Equilidem25

**Combined Pharmaceutical Dose Form** : tablet

**Indication** : Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

**Legal Status Of Supply** : Prescription only medicine

**classification** : B01A

**Ingredients** :

> **Role** : active
> 
> > **substance** : Equilidonium Phosphate
> > 
> > | \- | **Presentation** |
> > | --- | --- |
> > | \* | 22 ml/1 tablet |

> **Role** : excipient
> 
> > **substance** : Calcium Carbonate
> > 
> > | \- | **Presentation** |
> > | --- | --- |
> > | \* | 3 ml/tablet |

### Names

| \- | **ProductName** |
| --- | --- |
| \* | Equilidem 2.5 mg film-coated tablets |

### Cross References

| \- | **Product** |
| --- | --- |
| \* | Link to generic equivalent |

### Manufacturing Business Operations

| \- | **Manufacturer** |
| --- | --- |
| \* | EquiliDrugCo Processing Inc. |

## Example XML



```xml
<?xml version="1.0" encoding="UTF-8"?>
<MedicinalProductDefinition xmlns="http://hl7.org/fhir" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../schema/medicinalproductdefinition.xsd">
	<id value="equilidem-with-ing-and-auth"/>
	<text>
		<status value="generated"/>
		<div xmlns="http://www.w3.org/1999/xhtml">
			<p>
				<b>
					Generated Narrative
				</b>
			</p>
			<p>
				<b>
					Id
				</b>
				: equilidem-with-ing-and-auth
			</p>
			<p>
				<b>
					Identifier
				</b>
				: Equilidem25
			</p>
			<p>
				<b>
					Combined Pharmaceutical Dose Form
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/dosefom tablet}">
					tablet
				</span>
			</p>
			<p>
				<b>
					Indication
				</b>
				: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
			</p>
			<p>
				<b>
					Legal Status Of Supply
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/legalstatusofsupply POM}">
					Prescription only medicine
				</span>
			</p>
			<p>
				<b>
					classification
				</b>
				:
				<span title="Codes: {http://www.whocc.no/atc/example B01A}">
					B01A
				</span>
			</p>
			<p>
				<b>
					Ingredients
				</b>
				:
			</p>
			<blockquote>
				<p>
					<b>
						Role
					</b>
					:
					<span title="Codes: {http://example.org.uk/fhir/ingredientType active}">
						active
					</span>
				</p>
				<blockquote>
					<p>
						<b>
							substance
						</b>
						:
						<span title="Codes: {http://example.org.uk/fhir/substances 123456}">
							Equilidonium Phosphate
						</span>
					</p>
					<table class="grid">
						<tr>
							<td>
								-
							</td>
							<td>
								<b>
									Presentation
								</b>
							</td>
						</tr>
						<tr>
							<td>
								*
							</td>
							<td>
								22 ml/1 tablet
							</td>
						</tr>
					</table>
				</blockquote>
			</blockquote>
			<blockquote>
				<p>
					<b>
						Role
					</b>
					:
					<span title="Codes: {http://example.org.uk/fhir/ingredientType excipient}">
						excipient
					</span>
				</p>
				<blockquote>
					<p>
						<b>
							substance
						</b>
						:
						<span title="Codes: {http://example.org.uk/fhir/substances 456789}">
							Calcium Carbonate
						</span>
					</p>
					<table class="grid">
						<tr>
							<td>
								-
							</td>
							<td>
								<b>
									Presentation
								</b>
							</td>
						</tr>
						<tr>
							<td>
								*
							</td>
							<td>
								3 ml/tablet
							</td>
						</tr>
					</table>
				</blockquote>
			</blockquote>
			<h3>
				Names
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							ProductName
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Equilidem 2.5 mg film-coated tablets
					</td>
				</tr>
			</table>
			<h3>
				Cross References
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Product
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Link to generic equivalent
					</td>
				</tr>
			</table>
			<h3>
				Manufacturing Business Operations
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Manufacturer
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						<span>
							EquiliDrugCo Processing Inc.
						</span>
					</td>
				</tr>
			</table>
		</div>
	</text>
	<!-- an authorization can also be contained if required (commented out temporarily due to build issues) -->
	<!--contained>
		<RegulatedAuthorization>
			<id value="authorization"/>
			<subject>
				<reference value="#"/>
			</subject>
			<type>
				<text value="Regulatory Drug Marketing Approval"/>
			</type>
			<status>
				<coding>
					<code value="active"/>
				</coding>
			</status>
			<statusDate value="2016-01-01"/>
			<holder>
				<display value="EquiliDrugCo Holdings Inc."/>
			</holder>
			<regulator>
				<display value="FDA"/>
			</regulator>
		</RegulatedAuthorization>
	</contained-->
	<contained>
		<Ingredient>
			<id value="EquilidoniumPhosphate"/>
			<status value="active"/>
			<for>
				<reference value="#"/>
			</for>
			<role>
				<coding>
					<system value="http://example.org.uk/fhir/ingredientType"/>
					<code value="active"/>
				</coding>
			</role>
			<substance>
				<code>
					<concept>
					<coding>
						<system value="http://example.org.uk/fhir/substances"/>
						<code value="123456"/>
						<display value="Equilidonium Phosphate"/>
					</coding>
					</concept>
				</code>
				<strength>
					<presentationRatio>
						<numerator>
							<value value="22"/>
							<unit value="ml"/>
							<system value="http://unitsofmeasure.org"/> 
							<code value="mL"/>
						</numerator>
						<denominator>
							<value value="1"/>
							<unit value="tablet"/>
						</denominator>
					</presentationRatio>
				</strength>
			</substance>
		</Ingredient>
	</contained>
	<contained>
		<Ingredient>
			<id value="CalciumCarbonate"/>
			<status value="active"/> 
			<for>
				<reference value="#"/>
			</for>
			<role>
				<coding>
					<system value="http://example.org.uk/fhir/ingredientType"/>
					<code value="excipient"/>
				</coding>
			</role>
			<substance>
				<code>
					<concept>
					<coding>
						<system value="http://example.org.uk/fhir/substances"/>
						<code value="456789"/>
						<display value="Calcium Carbonate"/>
					</coding>
					</concept>
				</code>
				<strength>
					<presentationRatio>
						<numerator>
							<value value="3"/>
							<unit value="ml"/>
							<system value="http://unitsofmeasure.org"/> 
							<code value="mL"/>
						</numerator>
						<denominator>
							<value value="1"/>
							<unit value="tablet"/>
						</denominator>
					</presentationRatio>
				</strength>
			</substance>
		</Ingredient>
	</contained>
	<identifier>
		<system value="http://example.org.uk/fhir/product"/>
		<value value="Equilidem25"/>
	</identifier>
	<combinedPharmaceuticalDoseForm>
		<coding>
			<system value="http://example.org.uk/fhir/dosefom"/>
			<code value="tablet"/>
		</coding>
	</combinedPharmaceuticalDoseForm>
	<indication value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults."/>
	<legalStatusOfSupply>
		<coding>
			<system value="http://example.org.uk/fhir/legalstatusofsupply"/>
			<code value="POM"/>
			<display value="Prescription only medicine"/>
		</coding>
	</legalStatusOfSupply>
	<classification>
		<coding>
			<system value="http://www.whocc.no/atc/example"/>
			<code value="B01A"/>
		</coding>
	</classification>
	<name>
		<productName value="Equilidem 2.5 mg film-coated tablets"/>
	</name>
	<crossReference>
		<product>
			<reference>
				<reference value="MedicinalProductDefinition/genericEquilidonium"/>
			</reference>
		</product>
	</crossReference>
	<operation>
		<organization>
			<display value="EquiliDrugCo Processing Inc."/>
			<!-- licence holder uses RegulatedAuthorization -->
		</organization>
	</operation>
</MedicinalProductDefinition>
```